Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of Artivion, Inc. (NYSE:AORT). In a filing disclosed on September 10th, the Representative disclosed that they had bought between $1,001 and $15,000 in Artivion stock on August 20th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Sold $1,001 – $15,000 in shares of DoorDash (NASDAQ:DASH) on 8/28/2026.
- Purchased $15,001 – $50,000 in shares of Quanta Services (NYSE:PWR) on 8/27/2026.
- Purchased $15,001 – $50,000 in shares of Eaton (NYSE:ETN) on 8/27/2026.
- Sold $15,001 – $50,000 in shares of NIKE (NYSE:NKE) on 8/27/2026.
- Sold $1,001 – $15,000 in shares of Phreesia (NYSE:PHR) on 8/26/2026.
- Purchased $1,001 – $15,000 in shares of Wheaton Precious Metals (NYSE:WPM) on 8/26/2026.
- Purchased $1,001 – $15,000 in shares of Walmart (NASDAQ:WMT) on 8/26/2026.
- Purchased $1,001 – $15,000 in shares of The Goldman Sachs Group (NYSE:GS) on 8/26/2026.
- Sold $15,001 – $50,000 in shares of Lamar Advertising (NASDAQ:LAMR) on 8/25/2026.
- Sold $1,001 – $15,000 in shares of Phreesia (NYSE:PHR) on 8/25/2026.
Artivion Trading Up 1.9%
AORT stock traded up $0.48 during midday trading on Friday, hitting $25.13. The company had a trading volume of 547,889 shares, compared to its average volume of 603,561. The company has a current ratio of 3.47, a quick ratio of 2.51 and a debt-to-equity ratio of 0.82. Artivion, Inc. has a 52 week low of $19.16 and a 52 week high of $48.25. The stock has a market cap of $1.23 billion, a price-to-earnings ratio of -358.92 and a beta of 1.25. The stock’s 50 day moving average price is $26.27 and its 200 day moving average price is $28.78.
Hedge Funds Weigh In On Artivion
Institutional investors and hedge funds have recently made changes to their positions in the business. Caitong International Asset Management Co. Ltd purchased a new position in shares of Artivion in the 3rd quarter worth about $27,000. Rockefeller Capital Management L.P. increased its stake in Artivion by 150.0% during the 4th quarter. Rockefeller Capital Management L.P. now owns 665 shares of the company’s stock valued at $30,000 after purchasing an additional 399 shares in the last quarter. Larson Financial Group LLC increased its stake in Artivion by 148.5% during the 4th quarter. Larson Financial Group LLC now owns 942 shares of the company’s stock valued at $43,000 after purchasing an additional 563 shares in the last quarter. Smartleaf Asset Management LLC raised its holdings in Artivion by 47.7% in the second quarter. Smartleaf Asset Management LLC now owns 1,667 shares of the company’s stock worth $52,000 after buying an additional 538 shares during the last quarter. Finally, Kemnay Advisory Services Inc. purchased a new position in Artivion in the fourth quarter worth about $79,000. Institutional investors own 86.37% of the company’s stock.
Analyst Upgrades and Downgrades
A number of analysts recently commented on AORT shares. Citigroup reaffirmed a “market outperform” rating on shares of Artivion in a research note on Tuesday, July 21st. Weiss Ratings downgraded shares of Artivion from a “sell (d+)” rating to a “sell (d-)” rating in a research report on Tuesday, August 11th. Wall Street Zen cut shares of Artivion from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. Canaccord Genuity Group increased their price target on shares of Artivion from $39.00 to $40.00 and gave the stock a “buy” rating in a research note on Tuesday, August 18th. Finally, Needham & Company LLC restated a “buy” rating and issued a $44.00 price objective on shares of Artivion in a report on Monday, July 20th. Seven research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, Artivion has a consensus rating of “Moderate Buy” and a consensus target price of $44.83.
Check Out Our Latest Report on AORT
Insider Transactions at Artivion
In other Artivion news, CEO James P. Mackin sold 70,000 shares of the stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $28.95, for a total transaction of $2,026,500.00. Following the sale, the chief executive officer directly owned 877,275 shares in the company, valued at approximately $25,397,111.25. This trade represents a 7.39% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Jean F. Holloway sold 977 shares of Artivion stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $28.49, for a total value of $27,834.73. Following the completion of the sale, the senior vice president directly owned 184,118 shares of the company’s stock, valued at approximately $5,245,521.82. The trade was a 0.53% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 90,460 shares of company stock worth $2,557,366. Corporate insiders own 6.30% of the company’s stock.
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
Artivion Company Profile
Artivion, Inc (NYSE: AORT) is a global medical technology company that develops, manufactures and markets implantable tissue products and surgical devices for cardiac and vascular surgery. The company’s portfolio includes biologic implants derived from human and animal tissue, such as allografts and xenografts, as well as synthetic scaffolds and surgical adhesives. These products are designed to repair, reinforce or replace damaged cardiovascular and thoracic tissues during procedures such as aortic repair, heart valve surgery and vascular reconstruction.
Originally founded in 1984 under the name CryoLife, the company rebranded as Artivion in early 2022 to reflect its broader mission in cardiovascular innovation.
Recommended Stories
- Five stocks we like better than Artivion
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for Artivion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Artivion and related companies with MarketBeat.com's FREE daily email newsletter.
